These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 37376587)

  • 81. COVID-19 induced liver injury from a new perspective: Mitochondria.
    Akbari H; Taghizadeh-Hesary F
    Mitochondrion; 2023 May; 70():103-110. PubMed ID: 37054906
    [TBL] [Abstract][Full Text] [Related]  

  • 82. COVID-19-related liver injury: Mechanisms, diagnosis, management; its impact on pre-existing conditions, cancer and liver transplant: A comprehensive review.
    Vinutha M; Sharma UR; Swamy G; Rohini S; Vada S; Janandri S; Haribabu T; Taj N; Gayathri SV; Jyotsna SK; Mudagal MP
    Life Sci; 2024 Nov; 356():123022. PubMed ID: 39214285
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Liver injury in COVID-19: an insight into pathobiology and roles of risk factors.
    Tazarghi A; Bazoq S; Taziki Balajelini MH; Ebrahimi M; Hosseini SM; Razavi Nikoo H
    Virol J; 2024 Mar; 21(1):65. PubMed ID: 38491495
    [TBL] [Abstract][Full Text] [Related]  

  • 84. COVID-19-associated liver injury: from bedside to bench.
    Li D; Ding X; Xie M; Tian D; Xia L
    J Gastroenterol; 2021 Mar; 56(3):218-230. PubMed ID: 33527211
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Molecular mechanisms underlying SARS-CoV-2 hepatotropism and liver damage.
    Quarleri J; Delpino MV
    World J Hepatol; 2024 Jan; 16(1):1-11. PubMed ID: 38313242
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Insight into the liver dysfunction in COVID-19 patients: Molecular mechanisms and possible therapeutic strategies.
    Khullar N; Bhatti JS; Singh S; Thukral B; Reddy PH; Bhatti GK
    World J Gastroenterol; 2023 Apr; 29(14):2064-2077. PubMed ID: 37122601
    [TBL] [Abstract][Full Text] [Related]  

  • 87. COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023?
    Michalak A; Lach T; Szczygieł K; Cichoż-Lach H
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396888
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Liver Damage and Exposure to Toxic Concentrations of Endogenous Retinoids in the Pathogenesis of COVID-19 Disease: Hypothesis.
    Mawson AR; Croft AM; Gonzalez-Fernandez F
    Viral Immunol; 2021; 34(6):376-379. PubMed ID: 33983857
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Spectrum of COVID-19 induced liver injury: A review report.
    Singh L; Kumar A; Rai M; Basnet B; Rai N; Khanal P; Lai KS; Cheng WH; Asaad AM; Ansari S
    World J Hepatol; 2024 Apr; 16(4):517-536. PubMed ID: 38689748
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Acute severe hepatitis and COVID-19: case report.
    Hmimass S; Kadiri M; Borahma M; Chabib FZ; Berhili C; Lagdali N; Elbarhdadi IB; Ajana FZ
    Pan Afr Med J; 2024; 49():2. PubMed ID: 39372691
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Findings of Hepatic Severe Acute Respiratory Syndrome Coronavirus-2 Infection.
    Fiel MI; El Jamal SM; Paniz-Mondolfi A; Gordon RE; Reidy J; Bandovic J; Advani R; Kilaru S; Pourmand K; Ward S; Thung SN; Schiano T
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):763-770. PubMed ID: 32992052
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease.
    Li J; Fan JG
    J Clin Transl Hepatol; 2020 Mar; 8(1):13-17. PubMed ID: 32274341
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Safety and effectiveness of SARS-CoV-2 vaccines for patients with intractable hepatobiliary diseases: A multicenter, questionnaire-based, cross-sectional study.
    Tanifuji A; Ohfuji S; Matsumoto K; Abe M; Komori A; Takahashi A; Kawata K; Sato K; Joshita S; Umemura T; Ueno M; Nakayama N; Kakisaka K; Arinaga-Hino T; Ito K; Kanai S; Miura R; Arizumi T; Asaoka Y; Ito T; Shimizu T; Yoshida H; Ohta M; Mizuno S; Isayama H; Morimoto Y; Mochida S; Ohira H; Tanaka A
    Hepatol Res; 2024 Jul; 54(7):706-715. PubMed ID: 38300669
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Insight into COVID-19 associated liver injury: Mechanisms, evaluation, and clinical implications.
    Nasir N; Khanum I; Habib K; Wagley A; Arshad A; Majeed A
    Hepatol Forum; 2024; 5(3):139-149. PubMed ID: 39006140
    [TBL] [Abstract][Full Text] [Related]  

  • 95. COVID-19 and the liver: A brief and core review.
    Kayaaslan B; Guner R
    World J Hepatol; 2021 Dec; 13(12):2013-2023. PubMed ID: 35070005
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Severe Hepatitis in Pediatric Coronavirus Disease 2019.
    Antala S; Diamond T; Kociolek LK; Shah AA; Chapin CA
    J Pediatr Gastroenterol Nutr; 2022 May; 74(5):631-635. PubMed ID: 35149651
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Orchestrated regulation of immune inflammation with cell therapy in pediatric acute liver injury.
    Duan M; Liu X; Yang Y; Zhang Y; Wu R; Lv Y; Lei H
    Front Immunol; 2023; 14():1194588. PubMed ID: 37426664
    [TBL] [Abstract][Full Text] [Related]  

  • 98. COVID-19 associated liver injury: A general review with special consideration of pregnancy and obstetric outcomes.
    Cooper KM; Colletta A; Asirwatham AM; Moore Simas TA; Devuni D
    World J Gastroenterol; 2022 Nov; 28(42):6017-6033. PubMed ID: 36405386
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Impact of COVID-19 in Liver Disease Progression.
    Martinez MA; Franco S
    Hepatol Commun; 2021 Jul; 5(7):1138-1150. PubMed ID: 34533001
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series.
    Abenavoli L; Aquila I; Sacco MA; Scarlata GGM; Procopio AC; Boccuto L; Scarpellini E; Greco M; Foti DP; Ricci P; Luzza F
    Diseases; 2023 Oct; 11(4):. PubMed ID: 37873785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.